Lam Research Co. (NASDAQ:LRCX – Free Report) – Stock analysts at Zacks Research lowered their FY2026 earnings per share (EPS) estimates for Lam Research in a research note issued to investors on Tuesday, November 19th. Zacks Research analyst R. Department now anticipates that the semiconductor company will post earnings per share of $4.06 for the year, down from their prior estimate of $4.08. The consensus estimate for Lam Research’s current full-year earnings is $3.52 per share. Zacks Research also issued estimates for Lam Research’s Q4 2026 earnings at $1.09 EPS and FY2027 earnings at $4.67 EPS.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.81 by $0.05. The company had revenue of $4.17 billion for the quarter, compared to analysts’ expectations of $4.06 billion. Lam Research had a return on equity of 50.60% and a net margin of 26.02%. The business’s revenue for the quarter was up 19.7% compared to the same quarter last year. During the same period in the previous year, the business posted $6.85 EPS.
Get Our Latest Stock Report on LRCX
Lam Research Stock Up 4.3 %
LRCX opened at $73.05 on Thursday. Lam Research has a twelve month low of $68.72 and a twelve month high of $113.00. The company’s 50-day moving average price is $76.97 and its two-hundred day moving average price is $87.46. The stock has a market cap of $93.99 billion, a price-to-earnings ratio of 23.61, a PEG ratio of 1.12 and a beta of 1.48. The company has a quick ratio of 1.74, a current ratio of 2.53 and a debt-to-equity ratio of 0.53.
Institutional Trading of Lam Research
A number of hedge funds have recently bought and sold shares of LRCX. CarsonAllaria Wealth Management Ltd. bought a new stake in shares of Lam Research in the 2nd quarter worth approximately $32,000. RFP Financial Group LLC boosted its position in Lam Research by 52.2% during the second quarter. RFP Financial Group LLC now owns 35 shares of the semiconductor company’s stock valued at $37,000 after buying an additional 12 shares during the period. Hobbs Group Advisors LLC bought a new position in shares of Lam Research during the second quarter valued at about $40,000. Country Trust Bank purchased a new position in shares of Lam Research in the second quarter worth about $43,000. Finally, MFA Wealth Advisors LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at about $45,000. Institutional investors own 84.61% of the company’s stock.
Insiders Place Their Bets
In other news, CAO Christina Correia sold 647 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $817.51, for a total value of $528,928.97. Following the completion of the transaction, the chief accounting officer now directly owns 4,267 shares in the company, valued at approximately $3,488,315.17. This represents a 13.17 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.29% of the company’s stock.
Lam Research Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 8th. Shareholders of record on Wednesday, December 11th will be given a dividend of $0.23 per share. The ex-dividend date of this dividend is Wednesday, December 11th. This represents a $0.92 annualized dividend and a yield of 1.26%. Lam Research’s payout ratio is presently 29.74%.
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories
- Five stocks we like better than Lam Research
- Investing In Automotive Stocks
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- How to Invest in Biotech Stocks
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- The Role Economic Reports Play in a Successful Investment Strategy
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.